PsychedeLinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Oregon Psilocybin Services Act
In Rural Oregon, Psilocybin Is On the Ballot – But Still a Mystery
This election, more than two thirds of Oregon’s counties will vote on whether to opt out of the state’s new psilocybin program. But the program will start next year in 137 cities and 10 urban counties, regardless. Opting out is largely a rural discussion and in some places, there’s not much discussi…
Lake Oswego May Ban Psilocybin Centers as It Mulls Regulations
The City Council expresses preference for initial ban of the psychedelic treatment, which was legalized statewide and is said to help with behavioral disorders.
Voters Could Ban Psilocybin Centers in Many Oregon Cities
On January 1, Oregon will become the first state in the country to allow people to use psilocybin in supervised service centers. However, there are 100 cities and 27 unincorporated counties through…
Legalization, Decriminalization, & Other State Efforts
Seeking Psychedelics? Check the Data Privacy Clause.
Colorado’s Proposition 122 wants to let people take psilocybin at healing centers. But sensitive data isn’t covered by medical privacy protections.
Congressman Predicts Colorado Psychedelics Legalization Initiative Will Pass Next Week, And The Trend Will ‘Continue’
A congressman says that he expects that Colorado voters will make history again next week by passing a ballot initiative to legalize the possession of certain psychedelics and create psilocybin therapy centers in the state. Rep. Earl Blumenauer (D-OR) told Marijuana Moment late last month that he “a…
Therapists Who Already Incorporate Psychedelics in Their Practice are Mixed on Prop 122
The proposition would allow people to consume psilocybin in licensed settings and some therapists are concerned about how exactly that might work.
Research, Therapy, & Science
Psychedelic Research Bulletin: October 2022
October was a relatively quiet month for psychedelic research. Nonetheless, we still gained some valuable new insights into the world of psychedelics. Natural language processing (NLP) was used to…
COMPASS Pathways Announces Publication of Phase 2b Study of COMP360 Psilocybin Therapy
After a single 25mg dose of COMP360 psilocybin therapy, approximately 30% of patients with treatment-resistant depression (TRD) were in remission at...
US Veterans with PTSD Turn to Psychedelic Drugs Overseas as VA Frustration Grows
A growing number of veterans are turning to psychedelic drugs to treat PTSD and other ailments, even though these therapies are impossible to access in the U.S.
North America’s First Take Home Psilocybin Trial Approved in Canada
Participants will be allowed to take home psilocybin in a study examining its effects on depression and post-traumatic stress disorder.
Psychedelics to Take Spotlight at Wonderland’s Second Edition
As the Wonderland conference gears up for its second year, Microdose, the organizer of what has become one of the biggest psychedelics events in the world, knows it wants to make an impact.The promise of psychedelics-based medicines that can help patients with mental health struggles has only grown…
Subscribe to PsychedeLinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
PsychedeLinks by Emerge Law Group
PsychedeLinks is a weekly brief on news, business, and culture in the psychedelics industry curated by members of Emerge Law Group's groundbreaking Psychedelics Industry Group.